Home - Products - Others - Other Targets - [D-Tyr27,36, D-Thr32]-Neuropeptide Y, human

[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human

CAS No. ———

[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human( ——— )

Catalog No. M41464 CAS No. ———

[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [D-Tyr27,36, D-Thr32]-Neuropeptide Y, human
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Tyr27,36, D-Thr32]-Neuropeptide Y, human
  • Description
    [D-Tyr27,36, D-Thr32]-Neuropeptide Y, human
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    4271.8
  • Molecular Formula
    C189H285N55O57S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nemvaleukin alfa

    Nemvaleukin alfa (ALKS 4230) is an interleukin 2 fusion protein, a selective agonist of the medium-affinity IL-2 receptor, produced by fusion of the IL-2Ralpha subunit of the circularly arranged interleukin-2 (IL-2) and IL-2 receptor (IL-2R) complexes, which drives antitumor Immunity and inhibits tumor growth in small cell lung cancer.

  • Prolactin-Releasing ...

    Prolactin-Releasing Peptide (12-31), rat is a fragment of the prolactin releasing peptide (PrRP). Prolactin-Releasing Peptide (12-31), rat shows high affinity for GPR10 receptors. Prolactin-Releasing Peptide (12-31), stimulates calcium mobilization in CHOK1 cells transfected with the PrRP receptor.

  • HS271

    HS271 is a highly potent, orally active and selective IRAK4 inhibitor, with an IC50 of 7.2 μM. HS271 exhibits superior enzymatic and cellular activities, as well as excellent pharmacokinetic properties.